{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:04:14Z","timestamp":1783649054150,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013873","name":"Government of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["18207"],"award-info":[{"award-number":["18207"]}],"id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["60DK020541"],"award-info":[{"award-number":["60DK020541"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["202477"],"award-info":[{"award-number":["202477"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ebiom.2020.102973","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:33:02Z","timestamp":1599136382000},"page":"102973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy"],"prefix":"10.1016","volume":"59","author":[{"given":"Sylvia S.W.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun Ho","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin J.","family":"Kurland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102973_bib0001","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0003","doi-asserted-by":"crossref","first-page":"e79854","DOI":"10.1371\/journal.pone.0079854","article-title":"Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma","volume":"8","author":"Yoon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102973_bib0004","article-title":"Local control after stereotactic body radiation therapy for liver tumors","author":"Ohri","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ebiom.2020.102973_bib0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","article-title":"Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma","volume":"111","author":"Culleton","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0006","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.semradonc.2017.04.002","article-title":"Radiation-induced liver toxicity","volume":"27","author":"Munoz-Schuffenegger","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0007","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2013.02.013","article-title":"Radiation induces aerobic glycolysis through reactive oxygen species","volume":"106","author":"Zhong","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0008","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2015.08.016","article-title":"Nuclear EGFR renders cells radio-resistant by binding mRNA species and triggering a metabolic switch to increase lactate production","volume":"116","author":"Dittmann","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124795","article-title":"Integrative metabolic signatures for hepatic radiation injury","volume":"10","author":"Kurland","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102973_bib0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ebiom.2020.102973_bib0012","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc: series B"},{"key":"10.1016\/j.ebiom.2020.102973_bib0013","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Annals Stats"},{"key":"10.1016\/j.ebiom.2020.102973_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7512159","article-title":"Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities","volume":"2018","author":"De Matteis","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ebiom.2020.102973_bib0015","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/liv.12541","article-title":"Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC\/MS and UPLC\/MS-MS","volume":"34","author":"Fitian","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.ebiom.2020.102973_bib0016","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/elps.201200629","article-title":"Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC\/IT-TOF MS","volume":"34","author":"Chen","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ebiom.2020.102973_bib0017","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.18632\/oncotarget.23494","article-title":"Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers","volume":"9","author":"Lu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2020.102973_bib0018","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/0008-5472.CAN-11-0885","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling","volume":"71","author":"Patterson","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2020.102973_bib0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2018.10.039","article-title":"Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma","volume":"488","author":"Han","year":"2019","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.ebiom.2020.102973_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/10409238.2012.735643","article-title":"The role of phosphatidylcholine and choline metabolites to cell proliferation and survival","volume":"48","author":"Ridgway","year":"2013","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-9-71","article-title":"Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma","volume":"9","author":"Wu","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ebiom.2020.102973_bib0022","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.3390\/ijms20133360","article-title":"Metabolomic studies of tissue injury in nonhuman primates exposed to gamma-radiation","volume":"20","author":"Cheema","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2020.102973_bib0023","doi-asserted-by":"crossref","first-page":"122250","DOI":"10.1016\/j.jchromb.2020.122250","article-title":"An improved pseudotargeted GC-MS\/MS-based metabolomics method and its application in radiation-induced hepatic injury in a rat model","volume":"1152","author":"Wu","year":"2020","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ebiom.2020.102973_bib0024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-030-22254-3_11","article-title":"Discovery of metabolic biomarkers predicting radiation therapy late effects in prostate cancer patients","volume":"1164","author":"Cheema","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ebiom.2020.102973_bib0025","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/acs.jproteome.5b01032","article-title":"Sequential serum metabolomic profiling after radiofrequency ablation of hepatocellular carcinoma reveals different response patterns according to etiology","volume":"15","author":"Goossens","year":"2016","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ebiom.2020.102973_bib0026","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1440-1746.2005.03901.x","article-title":"Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: emphasis on sampling variability","volume":"20","author":"Lee","year":"2005","journal-title":"J Gastroenterol Hepatol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:32:44Z","timestamp":1778873564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420303492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"alternative-id":["S2352396420303492"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102973","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102973"}}